Archive · 5 Sep 2025
India's Bioeconomy Surges with Growth and Sustainability Focus
India's bioeconomy, which includes things like healthcare and farming, has grown a lot in the last 10 years.
It's now worth a lot of money and aims to grow even more.
India is making more vaccines and is a big supplier to the world.
Also, India is using more ethanol in petrol, which helps the environment and gives farmers more money.
The government has created a new policy to support this growth by promoting better manufacturing practices and sustainable methods to reduce emissions and promote recycling and efficient practices.
India's bioeconomy expanded to $165.7 billion in 2024, up from $10 billion in 2014.
Key subsectors include BioIndustrial, BioPharma, BioAgri, and BioResearch.
India is a top vaccine manufacturer, with the Serum Institute of India holding a significant global market share.
India achieved 20% ethanol blending in petrol in 2025, ahead of schedule.
The government launched the BioE3 Policy to promote sustainable biomanufacturing.
- Who
- India's bioeconomy
- What
- Significant growth and development
- When
- Over the past decade and into the future
- Where
- India
- Why
- Driven by biotechnology, agricultural innovation, and government policies
- Bioeconomy Value (2024)
- $165.7 billion
- Bioeconomy Growth (2014-2024)
- From $10 billion
- Ethanol Blending Target
- 20% in petrol
- Ethanol Blending Achievement
- Five years ahead of schedule
- Vaccine Market Share (Serum Institute, 2023)
- 24%
- Crude Oil Substitution (Ethanol Blending)
- 245 lakh metric tonnes
Sources
The ‘China Plus One’ gold rush: 3 Indian pharma stocks making the most of it
In framing new clinical trial rules, government must balance pace with prudence
Indegene stock up 2% as new Pune facility opens; key details
The Future of Generic Medicine Retail in India
